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nine chondrocytes. By looking at cartilage proteins expression and
degradative enzymes activity, we hope to identify GDF-5 action on
OA cartilage homeostasis.
Methods: Human OA chondrocytes were isolated from patients
undergoing knee replacement. Canine OA chondrocytes were
generated from the Nuki-Pond dog model. After in vitro expansion,
chondrocytes were co-incubated with increasing concentrations of
rhGDF-5. Expression of selected markers of cartilage metabolism
(aggrecans, type-I and -II collagen, ADAMST-4 and -5) was ana-
lyzed at the mRNA and protein levels using qRT-PCR and western
blot respectively. Aggrecans degradation products, which reﬂect
the activity of aggrecanases, were also analyzed by western blot
following GDF-5 stimulation.
Results: Similar responses were recorded in human and canine
chondrocytes. Stimulation of human and canine OA chondrocytes
with rhGDF-5 led to a dose-dependent increase of aggrecans and
type II/type I collagen ratio, with a concomitant decrease in both
ADAMTS-4 and ADAMTS-5 mRNA expression. A similar action
for rhGDF-5 was observed for aggrecans and ADAMTS-4 and
ADAMTS-5 at the protein level. Finally, aggrecans degradation
products were also signiﬁcantly decreased in OA chondrocytes
following rhGDF-5 stimulation.
Conclusions: Interestingly, the addition of rhGDF-5 had a dual
effect on OA chondrocytes, increasing markers of anabolic ac-
tivity and decreasing catabolic enzymes expression and activity.
These results suggest a key role for GDF-5 in maintaining carti-
lage homeostasis, an action that could be loss in OA. Because
GDF-5 concentrations are constant in normal and OA cartilage,
interference with GDF-5 signalling may occur in OA, an anomaly
that appears to be recovered by the addition of rhGDF-5. Further
in vivo studies will evaluate the potential of GDF-5 as a disease
modifying drug in OA.
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INTERACTION BETWEEN 4-HYDROXYNONENAL-MODIFIED
EXTRACELLULAR MATRIX AND OSTEOARTHRITIC
CHONDROCYTES OR OSTEOBLASTS INDUCES CHANGES
IN CELL PHENOTYPE AND FUNCTION
R. El Bikai, Q. Shi, H. Fahmi, M. Benderdour
Univ. of Montreal, Montreal, QC, Canada
Purpose: Extracellular matrix (ECM) degradation and formation
are closely linked and tightly regulated in order to maintain carti-
lage and bone homeostasis. In cartilage and bone, accumulation
of 4-hydroxynonenal (HNE), a product of lipid peroxidation (LPO),
undergoes considerable alterations in ECM structure and thereby
rendering it more prone to mechanical damage. This study aimed
to demonstrate that interaction between HNE-modiﬁed extracel-
lular matrix and chondrocytes or osteoblasts induced changes in
cell morphology and function of these cells.
Methods: Plates culture were coated with 0.1 mg/well type II
collagen (Col II) and then modiﬁed by increasing concentrations
of HNE (0.1 to 2 mM). Chondrocytes or osteoblasts where then
incubated for 48 hrs in appropriate culture medium. Cell viability
was evaluated by MTT test. The protein expression of adhe-
sion molecules such as integrin αVβ3 and inter-cellular adhesion
molecule-1 (ICAM-1) is performed by Western blot. The level of
matrix metalloproteinase-13 (MMP-13), prostaglandin 2 (PGE2)
and osteocalcin (OC) was determined by ELISA using commercial
kits. Alkaline phosphatase (ALPase) activity was measured as the
release of p-nitrophenol hydrolysed from p-nitrophenyl phosphate.
Results: After 48 hrs of incubation, the modiﬁcation of Col II with 2
mM HNE induces shape change of chondrocytes and osteoblasts
from elongated phenotype to rounded phenotype with a 10% de-
crease in cell viability. At a functional level, the modiﬁcation of Col
II with 0.1-0.5 mM HNE enhanced the production of integrin αVβ3,
ICAM-1, MMP-13 and PGE2 in chondrocytes, and OC release and
ALPase activity in osteoblasts. In contrast, the modiﬁcation of Col
II with 1 and 2 mM HNE reduced their production in both cell
types.
Conclusions: Our results showed that interaction between HNE-
modiﬁed Col II and chondrocytes or osteoblasts induced changes
in cell phenotype of chondrocytes/osteoblasts and modulate the
expression of catabolic and inﬂammatory factors. As described
previously by our laboratory, we suggest that accumulation of
HNE/Col II adducts in OA cartilage and bone may play a critical
role in OA pathogenesis
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DIFFERENTIAL RESPONSE OF CARTILAGE EXPLANTS TO
CLINICALLY-RELEVANT LEVELS OF IL-1 AND
FIBRONECTIN FRAGMENTS
P. DiBenedetto, F. Chen, M. DiMicco, G. Matthews
Genzyme Corp., Framingham, MA
Purpose: In vitro, it is known that high doses of recombinant
interleukin-1 (IL-1) causes rapid and extensive cartilage degrada-
tion characterized by loss of proteoglycan from tissue to surround-
ing culture medium. However, IL-1 is only one of several potentially
catabolic factors detected in synovial ﬂuid from osteoarthritic (OA)
joints, and has been shown to be present at much lower con-
centrations than those typically employed in vitro. Our goal was
to expose cartilage explants to levels of IL-1 similar to those we
measured in OA synovial ﬂuid, assess the loss of sulfated GAG
from the tissue, and determine the effect of IL-1 blockade using
IL-1 receptor antagonist (IL-1ra).
Methods: Levels of IL-1 were determined in synovial ﬂuid collected
from OA patients. Bovine articular cartilage was harvested from
the patellofemoral groove of 3 adult animals, and prepared as
full-thickness discs 6 mm in diameter. These cartilage explants
were equilibrated for 48 hours in medium (DMEM with 50 μg/mL
gentamicin), then transferred to culture wells containing fresh
medium supplemented with IL-1 alpha ranging from 5000 ng/mL
(often used for in vitro degradation studies) to more clinically-
relevant levels (200, 20, 16, 8, 4, 2, 1, 0.5, and 0 ng/mL), based
on measured levels from above. To assess the contribution of other
potential catabolic factors, some cultures were also supplemented
with 30 kDa N-terminal fragment of ﬁbronectin (Fn-f) at reported
physiologic concentration (0.8 μM). The effect of IL-1 blockade
was assessed by preincubating some cartilage samples with 1.4
nM IL-1ra for 2 hours before addition of IL-1 or Fn-f. After 4
days, culture media were collected and assayed for sulfated GAG
content by DMMB, normalized to initial tissue wet weight. GAG
distribution was also visualized in cartilage discs by safranin-O
staining.
Results: Incubation of cartilage with IL-1 gave a dose-dependent
decrease in sGAG release between 5000 and 20 pg/mL. The
GAG content of the culture medium was not different from control
explants (no IL-1) for the range 0.5-20 pg/mL IL-1. Similarly, there
was no difference in safranin-O histology in this dose range.
Addition of IL-1ra to the culture medium completely inhibited this
loss. However, when Fn-f was included in the culture medium,
GAG release was increased, and the additional degradation was
not able to be inhibited by IL-1ra.
Conclusions: In later-stage OA patients, we and others have
detected IL-1 at very low levels. Incubation of cartilage with IL-1
at these concentrations did not induce GAG release over that of
untreated cartilage explants. However, at least one other catabolic
factor, Fn-f, induced degradation at a more clinically-relevant con-
centration. It may be that in advanced stages of OA, the contribu-
tion of IL-1 to degradation is not as pronounced as that of other
catabolic factors. While IL-1 may be more involved in earlier OA,
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studies such as these may suggest different therapeutic targets
for treatment of later-stage OA.
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AML1 IS HIGHLY EXPRESSED IN HUMAN OSTEOARTHRITIC
CARTILAGE AND RESPONDS TO MECHANICAL LOADING
P.J. Fanning, K.T. LeBlanc, S.L. O’Connell, J.B. Lian, D.C. Ayers
Univ. of Massachusetts Med. Sch., Worcester, MA
Purpose: AML1 is known to be essential for the normal devel-
opment of hematopoietic stem cells. Pathologically, AML1 is one
of the most frequent targets of chromosome translocations asso-
ciated with leukemia. Although its role in chondroprogenitor cells
was established early on, few papers have since emerged more
clearly deﬁning its role in articular cartilage and more importantly,
osteoarthritis (OA). In this study, we have undertaken to examine
the functional expression patterns of AML1 in normal vs. OA ar-
ticular cartilage and its role in cartilage mechanotransduction, a
feature shared by other genes involved in cartilage homeostasis
and OA.
Methods: Medial vs. lateral human OA cartilage samples were
analyzed and compared through immunoblot analysis for the rel-
ative expression levels of AML1 on a knee-by-knee basis. Bovine
articular cartilage discs were harvested from the knees of newborn
male calves and compressed ex vivo in compression chambers,
to test whether AML1 is a mechanically-regulated gene. Samples
were then subjected to AML1 immunoblot analysis. Normal knee
articular cartilage from animal sources (bovine and mouse) as well
as human knee OA samples (comparing medial vs. lateral distal
femoral compartments) were analyzed IHC localization of AML1.
Results: Fig. 1 shows a signiﬁcant increase in AML1 protein
in the medial compartment of human OA varus knees. Similar
results were obtained in n=4 human OA knees. These initial re-
sults suggested that AML1 is a potentially mechanically regulable
gene product. Therefore, we tested the responsiveness of AML1
expression under increasing strains in bovine articular cartilage
(Fig. 2). Results indicated that AML1 is extremely sensitive to load,
Figure 1. Increased expression of AML-1 in varus human knee OA is restricted
to the medial compartment.
Figure 2. AML-1 is a mechanico-responsive gene in normal bovine articular car-
tilage.
Figure 3. IHC localization of articular cartilage AML-1 expression: bovine (A),
mouse (B), human OA: varus-lateral (C), varus-medial (D).
demonstrating a 5-fold increase in AML1 protein expression at 25
and 50% strain values. IHC data (Fig. 3) showed that in normal
bovine and mouse cartilage, the highest expression of AML1 is
localized in the most superﬁcial zone of articular cartilage. It is
interesting to note that it is the superﬁcial zone which experi-
ences the highest degree of tissue strain under mechanical load.
Human lateral (varus) OA cartilage showed patchy expression of
AML1, but was limited to the superﬁcial zone. Medial OA cartilage
showed that AML1 expression was limited to osteoarthritic ‘clones’
or aggregates of chondrocytes in areas immediately adjacent to
focal areas of superﬁcial ﬁbrillation.
Conclusions: Here we show that AML1 protein is normally ex-
pressed in a narrow margin of cells at the weight-bearing surfaces
of articular cartilage in both human and animal samples. Recent
studies have shown that stem cell markers (CD155+/CD166+),
indicative of the presence of mesenchymal progenitor cells, also
co-exist in the same narrow zone. Given these ﬁndings and
AML1’s known role in cell proliferation, it is interesting to speculate
that AML1 may be marking a progenitor cell population localized
in surfaces of articular cartilage. In osteoarthritic tissue, AML1
is overexpressed, particularly in the ‘non-spared’ compartments
of malaligned knees. Within this compartmentally-restricted ex-
pression pattern another sub-pattern of enhanced expression in
chondrocyte clones is seen which could be interpreted as an
indication that AML1 plays a role in phenotypic plasticity of chon-
drocytes in sub-populations of cells in both normal articular and
osteoarthritic cartilage.
237
POSITIVE REGULATION OF HUMAN OSTEOARTHRITIC
CHONDROCYTES UPON ACTIVATION OF THE EphB4
RECEPTOR BY ITS SPECIFIC LIGAND EPHRIN B2
S. Kwan Tat1, J.-P. Pelletier1, N. Amiable1, C. Boileau1,
M. Lavigne2, J. Martel-Pelletier1
1Osteoarthritis Reseach Unit, Notre-Dame Hosp., Univ. of
Montreal Hosp. Res. Ctr. (CRCHUM), Montreal, QC, Canada;
2Dept. of Orthopaedics, Maisonneuve-Rosemont Hosp., Montreal,
QC, Canada
Purpose: Osteoarthritis (OA) is characterized by cartilage degra-
dation resulting from an increase in catabolic factors and de-
creased anabolic properties. It has recently been demonstrated
that ephrin B2 and its speciﬁc receptor EphB4 are involved in
the control of bone homeostasis. Our group further revealed that
this ephrin system inhibits the pro-resorptive activity of human OA
subchondral bone.
To our knowledge, there has been no study on the implication of
ephrins in OA cartilage tissue. Thus, we investigated the possible
